INS and Obesity: This is the first randomized clinical trial to demonstrate that a low-energy TDR-based lifestyle intervention safely induces weight loss, reduces insulin requirements, and improves QoL specifically in participants with long-standing type 2 diabetes and obesity receiving IT.